Skip to content
★ Sign in to follow
KJ

Kathy Jo Fahey

Executive
Nuvectra Corp
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€478

Latest filing published 11 Apr 2017 for Nuvectra Corp, €7,451.

Filing timeline

BuySale
Kathy Jo Fahey

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

Kathy Jo Fahey: trading record in brief

All filings by Kathy Jo Fahey on record concern Nuvectra Corp. The record holds 4 filings, for trades running from 8 April 2016 to 7 April 2017.

The open-market record consists of 1 sale worth €478, with no purchase. The rest of the record consists of 1 share grant and 2 option exercises. Since January 2017: no purchases and 1 sale on the market.

The record was last updated on 11 April 2017 with an option exercise (€7,451) in Nuvectra Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Kathy Jo Fahey

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◇
    VP of Regulatory & ClinicalExecutivesNuvectra Corp
    7,931 USD19SEC
    1,247 shares@ US$6.3681.1% of flowCommon StockSEC:0001437749-17-006443:0
  • ◇
    VP of Regulatory & ClinicalExecutivesNuvectra Corp
    1,328 USD12SEC
    264 shares@ US$5.0313.7% of flowCommon StockSEC:0001437749-17-000151:0
  • ▼
    VP of Regulatory & ClinicalExecutivesNuvectra Corp
    498 USD24SEC
    93 shares@ US$5.365.2% of flowCommon StockSEC:0001437749-17-000151:1
  • ◆
    VP of Regulatory & ClinicalExecutivesNuvectra Corp
    0SEC
    3,741 shares0Common StockSEC:0001437749-16-029423:0

4 of 4 declarations